Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,704.33
+30.00
0.15%
Nifty
5,983.55
+16.50
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Parabolic Drugs Ltd
BSE: 533211 | NSE: PARABDRUGS | ISIN: INE618H01016
Market Cap: [Rs.Cr.] 39 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs
Discuss this stock
Company News
Feb 14, 2013
12:49
Parabolic Drugs reports net loss of Rs 25.59 crore in the December 2012 quarter
11:21
Parabolic Drugs' director resigns
Jan 09, 2013
16:07
Parabolic Drugs' directors resign
Nov 12, 2012
12:55
Parabolic Drugs reports net loss of Rs 25.25 crore in the September 2012 quarter
12:03
Parabolic Drugs to refer CDR cell for financial restructuring of debts
Aug 16, 2012
10:03
Parabolic Drugs recommends dividend
Aug 15, 2012
16:29
Parabolic Drugs net profit declines 35.70% in the June 2012 quarter
Aug 04, 2012
14:28
Parabolic Drugs to consider dividend
May 12, 2012
20:03
Parabolic Drugs net profit declines 40.11% in the March 2012 quarter
Mar 30, 2012
09:55
Parabolic Drugs gains on commissioning of new sterile plant
09:46
Parabolic Drugs announces commissioning of Sterile Cephalosporin Plant at Derabassi
Feb 13, 2012
10:18
Parabolic Drugs net profit rises 2.72% in the December 2011 quarter
Nov 12, 2011
19:33
Parabolic Drugs net profit rises 0.63% in the September 2011 quarter
Oct 31, 2011
10:45
Parabolic Drugs gets Japanese nod for Cephalosporin Drugs
Sep 03, 2011
12:38
Parabolic Drugs commissions its 8th multi-purpose plant at Derabassi facility
Prev
Next
India Infoline Research
Company
|
Sectors
Mr. Vineet Gupta, Executive Director, Parabolic Drugs Ltd.
Related News
Company
|
Sector
|
Latest
14-Feb-13
Parabolic Drugs reports net loss of Rs 25.59 crore in the December 2012 quarter
14-Feb-13
Parabolic Drugs' director resigns
09-Jan-13
Parabolic Drugs' directors resign
12-Nov-12
Parabolic Drugs reports net loss of Rs 25.25 crore in the September 2012 quarter
12-Nov-12
Parabolic Drugs to refer CDR cell for financial restructuring of debts
16-Aug-12
Parabolic Drugs recommends dividend
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin
34,460.10
27.34
7.11
21.23
23.4
22.7
0.30
Divi's Lab.
13,113.05
21.45
5.14
13.41
27.3
34.1
0.02
Jubilant Life
2,324.98
29.54
1.25
21.18
3.1
6.4
1.43
Shilpa Medicare
699.60
13.97
2.39
9.34
16.3
18.0
0.19
Hikal
668.29
26.19
1.95
5.65
22.4
18.2
1.53
Elder Pharma
584.57
6.35
0.76
6.59
12.9
13.0
1.25
Dishman Pharma.
547.55
11.31
0.81
5.44
6.8
10.2
0.80
Vinati Organics
538.41
7.84
2.23
5.63
33.2
31.3
0.75
Orchid Chemicals
414.25
0.00
0.45
7.67
9.7
8.3
1.75
Shasun Pharma.
411.48
14.93
1.52
7.48
14.0
8.9
1.05
Nectar Lifesci.
356.19
4.16
0.41
6.25
9.7
11.2
1.22
Sequent Scien.
335.72
0.00
2.20
7.62
-3.9
5.9
1.58
Suven Life Scie.
284.41
9.22
1.84
10.21
11.3
9.1
0.64
Aarti Drugs
260.37
5.72
1.25
4.78
13.5
13.7
1.48
Granules India
260.08
8.62
0.96
4.12
11.7
15.2
0.57
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Pranav Gupta , Managing Director
Vineet Gupta , Whole-time Director
Ram Kumar , Director
Arun Kumar Mathur , Director
Company Head Office / Quarters:
SCO 99-100 Top Floor,
Sector 17-B,
Chandigarh,
Chandigarh-160017
Phone : 91-172-3914646-647
Fax : 91-172-3914645
E-mail :
pdl.ipo@parabolicdrugs.com
Web :
http://www.parabolicdrugs.com
Registrars:
Link Intime India Pvt Ltd
C-13 Pannalal Silk
Mills Cmpd LBS Marg
Bhandup West
Mumbai - 400 078
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
UTI-CCP Balanced Fund (G)
297,545
Detailed List
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
India Finsec
View full month IPO calendar
Economic Events
No economic event today
View full month Economic Events calendar
Results
Bharat Forge | Oil India | Container Corpn.
View full month Results calendar